LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 1 of total 1

Search options

Article: Prognostic factors of recurrence in encapsulated Hurthle cell carcinoma of the thyroid gland: a clinicopathologic study of 50 cases.

Ghossein, Ronald A / Hiltzik, David H / Carlson, Diane L / Patel, Snehal / Shaha, Ashok / Shah, Jatin P / Tuttle, Robert M / Singh, Bhuvanesh

Cancer

2006  Volume 106, Issue 8, Page(s) 1669–1676

Abstract: ... on the encapsulated Hurthle cell carcinoma (EHC), the current study attempted to identify predictors of recurrence ... Hurthle cell carcinoma), are subdivided into the indolent encapsulated ("minimally invasive") and ... the clinically aggressive widely invasive tumors. There are, however, cases of encapsulated follicular carcinoma ...

Abstract Background: Follicular carcinomas of the thyroid gland, including its oncocytic variant (so-called Hurthle cell carcinoma), are subdivided into the indolent encapsulated ("minimally invasive") and the clinically aggressive widely invasive tumors. There are, however, cases of encapsulated follicular carcinoma that recur and metastasize. Identifying these cases at the time of diagnosis is crucial for prognostic and therapeutic considerations. Because to the authors' knowledge most studies do not focus exclusively on the encapsulated Hurthle cell carcinoma (EHC), the current study attempted to identify predictors of recurrence in EHC.
Methods: A tumor was defined as EHC if it was encapsulated, macroscopically well defined with microscopic but no macroscopic evidence of vascular or capsular invasion, and composed of > 75% follicular oncocytic cells. Retrospective chart review and microscopic examination identified 50 primary tumors meeting the above criteria at the Memorial Sloan-Kettering Cancer Center between 1967 and 2005. The cases were analyzed for various histologic and clinical parameters. Each parameter was correlated with recurrence-free survival (RFS).
Results: Seven of 50 (14%) patients developed disease recurrence. All patients who developed recurrence were found to have a high number of foci of vascular invasion (> or = 4). In univariate analysis, > or = 4 foci of vascular invasion (P <.0001), tumor size > 4 cm (P = .049), the presence of mitosis (P = .018), and a solid/trabecular growth pattern (P = .009) were found to be correlated with a decreased RFS. Extensive capsular invasion, gender, and age did not confer a statistically higher recurrence rate. The finding of a solid/trabecular growth and mitosis correlated with the presence of numerous foci (> or = 4) of vascular invasion (P = .01 and P = .005, respectively).
Conclusions: A diligent search for vascular invasion is recommended in EHC that display mitosis or a solid/trabecular growth pattern. The presence of > or = 4 foci of vascular invasion should alert the pathologist and the clinician to a significantly higher risk of recurrence in EHC.
MeSH term(s) Adenoma, Oxyphilic/pathology ; Adenoma, Oxyphilic/secondary ; Adenoma, Oxyphilic/therapy ; Combined Modality Therapy ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Prognosis ; Thyroid Neoplasms/pathology ; Thyroid Neoplasms/therapy ; Thyroidectomy
Language English
Publishing date 2006-04-15
Publishing country United States
Document type Journal Article
ZDB-ID 1429-1
ISSN 1097-0142 ; 0008-543X ; 1934-662X
ISSN (online) 1097-0142
ISSN 0008-543X ; 1934-662X
DOI 10.1002/cncr.21825
Shelf mark
Uh III Zs.146: Show issues Location:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Database MEDical Literature Analysis and Retrieval System OnLINE

More links

Kategorien

To top